ArticleCNS drugs2022

Long-Term Effectiveness of Three Anti-CGRP Monoclonal Antibodies in Resistant Chronic Migraine Patients Based on the MIDAS score.

Luigi Francesco Iannone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.